ACAM-FLU-A: Phase I started

ACM started a double-blind, placebo-controlled, U.S. Phase I trial in 80 healthy volunteers to evaluate ACAM-FLU-A alone and in conjunction with an aluminum hydroxide or QS-21 Stimulon adjuvant. ACM h...